A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Public ClinicalTrials.gov record NCT06858813. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV 324 in Adults With Hepatocellular Cancer or Squamous Cell Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT06858813
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 232 participants
Conditions and interventions
Interventions
- ABBV-324 Drug
- Lenvatinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2025
- Primary completion
- Aug 31, 2030
- Completion
- Aug 31, 2030
- Last update posted
- Mar 24, 2026
2025 – 2030
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center /ID# 270526 | Duarte | California | 91010 | Recruiting |
| City of Hope - Orange County Lennar Foundation Cancer Center /ID# 276120 | Irvine | California | 92618 | Recruiting |
| USC Norris Comprehensive Cancer Center /ID# 271573 | Los Angeles | California | 90033 | Recruiting |
| UC Irvine Medical Center /ID# 270507 | Orange | California | 92868-3201 | Recruiting |
| UCLA - Santa Monica /ID# 275995 | Santa Monica | California | 90404 | Recruiting |
| University of Chicago Medical Center /ID# 270517 | Chicago | Illinois | 60637 | Recruiting |
| Washington University /ID# 275757 | St Louis | Missouri | 63110 | Recruiting |
| Memorial Sloan Kettering Cancer Center /ID# 271228 | New York | New York | 10021-3459 | Recruiting |
| Thomas Jefferson University Sidney Kimmel Cancer Center /ID# 276269 | Philadelphia | Pennsylvania | 19107 | Recruiting |
| SCRI Oncology Partners /ID# 272750 | Nashville | Tennessee | 37203 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06858813, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06858813 live on ClinicalTrials.gov.